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Introduction {#sec1}
============

Genome integrity is continuously threatened by DNA damage arising from both exogenous and endogenous sources. However, the DNA damage response (DDR) pathway identifies and repairs damaged DNA to ensure that the genetic information is faithfully maintained. The eukaryotic genome is compacted into chromatin, whose fundamental repeating unit is the nucleosome. Nucleosomes consist of 147 base pairs of DNA tightly wrapped around a core histone octamer, which is composed of two copies of histones H2A, H2B, H3, and H4 ([@bib42]). Importantly, chromatin structure regulates all DNA-based processes, including the DDR. In this regard, histones are subject to post-translational modifications that change chromatin structure and provide docking sites for other proteins. These modifications are dynamically deposited and removed by chromatin-modifying enzymes in a tightly regulated manner ([@bib4]).

Histone post-translational modifications occur both in the tails and the core domains. One of the first-studied core modifications was methylation of histone H3 lysine 79 (H3K79me), which plays an important role in the DDR ([@bib19], [@bib66]). Since then, several novel histone modifications have been identified by mass spectrometry, with many of them being localized to the core domains. However, in contrast to those present in the tails, modifications in the core region of the nucleosome are far less characterized.

In response to DNA damage, cells activate a signal transduction cascade referred to as the DNA damage checkpoint (DDC), which results in a temporary cell cycle arrest and activation of DNA repair pathways ([@bib9]). The molecular mechanism regulating this signaling cascade was initially described in yeast, and later, it was shown to be conserved in mammals ([@bib17], [@bib24]). In *Saccharomyces cerevisiae*, Mec1 kinase orchestrates the DDC signaling process. Mec1 is first recruited to single-stranded DNA (ssDNA) through an interaction with replication protein A ([@bib48], [@bib74]) and then activated by two independent factors, Dpb11 and PCNA-like complex ([@bib49], [@bib57]). Two direct targets of Mec1 are histone H2A serine 129 (γH2A) and the checkpoint adaptor Rad9 ([@bib16], [@bib20]), which is recruited to sites of DNA damage via two different pathways: one relying on Dpb11 and the other one on H3K79me and γH2A ([@bib55], [@bib56]). Rad9 plays a crucial role in the signaling cascade, working as an adaptor between Mec1 and its target kinase Rad53, whose activation is essential for the coordination of the DDR ([@bib54]). Once fully activated, Rad53 is released from the Rad9 complex, leading to an amplification of the checkpoint signal ([@bib8]).

Whereas the molecular mechanisms regulating DDC activation are well understood, comparatively less is known about how DDC recovery is initiated and controlled. Even though different factors have been shown to be involved in the process ([@bib10], [@bib30], [@bib59], [@bib67]), the molecular mechanisms governing DDC recovery are still not apparent. However, this is a critically important process because persistent checkpoint activation is detrimental to cell viability ([@bib12]). Termination of the DDC requires inactivation of the downstream kinase Rad53 to allow resumption of the cell cycle. Although direct inactivation of Rad53 kinase can be achieved by the action of specific phosphatases ([@bib37], [@bib50]), full DDC recovery requires interruption of the upstream signaling cascade. In this context, it has been proposed that the Rtt107-Slx4 protein complex can outcompete Rad9 from γH2A and Dpb11 ([@bib13], [@bib51]). However, the mechanism regulating this transition still remains elusive. The findings presented here identify H4T80ph, a DNA-damage-regulated histone core modification, as a key regulator of the switch between DDC activation and DDC recovery.

Results {#sec2}
=======

H4T80ph Promotes Cell Survival in Response to DNA Damage {#sec2.1}
--------------------------------------------------------

Within nucleosomes, the lateral surface of the core histone octamer is in direct contact with the DNA and is of particular interest, because it is fundamental to nucleosome integrity and therefore has the potential to affect all DNA-based processes ([@bib33]). In this regard, the amino acid residues within the L2 loop of histone H4 are particularly noteworthy, because they contact both DNA and the L1 loop of histone H3 ([@bib42]). In order to shed some light on the function(s) of this specific region, we individually mutated every residue in the L2 loop of H4 (residues 77--82; [Figure 1](#fig1){ref-type="fig"}A) to alanine in *Saccharomyces cerevisiae* and investigated phenotypes of resulting strains. We observed that, in contrast to other mutations analyzed, mutation of either arginine 78 (H4R78A) or threonine 80 (H4T80A) results in severe hypersensitivity to the DNA-damaging agents camptothecin (CPT) and methyl methanesulfonate (MMS) ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Histone H4T80ph Promotes Cell Survival in Response to DNA Damage(A--C) (A, upper) Sequence of yeast histone H4 L2 loop. (A, lower; B and C) Spot test for DNA damage sensitivity of yeast cells harboring different histone H4 point mutations as indicated. 10-fold serial dilutions were used.(D) Immunoblot analysis of purified yeast histones. Cells were arrested in G1 using α factor and then released in the absence or presence of 20 μM CPT for 45 min. Purified yeast histones were separated by SDS-PAGE in 17% acrylamide gels. Blots were probed with anti-H4T80ph antibody and then re-probed with anti-H4 antibody as indicated.(E) ChIP-qPCR experiments showing H4T80ph recruitment to the DSB site after galactose induction. *PRP8* locus was used as a negative control. Data are represented as mean + SEM of three biological replicates (^∗^p \< 0.05; t test).

We initially focused on the possible role of H4R78 in the DDR. H4R78 forms hydrogen bonds with histone H4 aspartate 85 (H4D85) ([Figure S1](#mmc1){ref-type="supplementary-material"}A), but disruption of this salt bridge by H4D85A mutation does not elicit DNA damage hypersensitivity ([Figure 1](#fig1){ref-type="fig"}B), suggesting that this interaction is not necessary for the DDR. We then asked whether methylation of H4R78 might be required for DNA damage resistance. However, mutation of H4R78 to lysine does not cause DNA damage hypersensitivity ([Figure 1](#fig1){ref-type="fig"}B), indicating that the presence of a basic amino acid residue at position 78 is sufficient for cell viability in response to DNA damage.

Although H4T80 could exert its functions in various ways, we were intrigued by the possibility that it might be phosphorylated in a manner requiring a basic amino acid residue at position 78. In this regard, certain basophilic protein kinases are known to target either threonine or serine preceded by basic residues ([@bib46]). In agreement with the hypothesis that H4T80 phosphorylation may be required for DNA damage resistance, mutation of this residue to serine, which can also be substrate of basophilic kinases, largely rescues the DNA damage hypersensitivity of the H4T80A mutants ([Figure 1](#fig1){ref-type="fig"}C). Interestingly, mutation of H4T80 to either aspartic acid or glutamic acid, which can mimic a permanent phosphorylated state, causes cell death ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Collectively, these results suggest that phosphorylation of H4T80 is important for cell survival in response to DNA damage.

Different large-scale mass spectrometry studies identified histone H4T80ph in higher eukaryotes ([@bib7], [@bib26], [@bib43], [@bib45], [@bib52], [@bib53], [@bib64]). However, its function still remains completely unexplored. To investigate the possible role of H4T80 phosphorylation in the DDR, we raised an antibody against H4T80ph, whose specificity was first assessed by peptide dot-blot analysis. This antibody specifically recognizes H4T80ph peptides, but not other H4 phospho-peptides, such as H4T30ph or H4T96ph ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Moreover, the antibody does not recognize histone H3T80ph peptides, in which the phosphorylated threonine is also preceded by a basic residue ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Immunoblot studies using purified yeast histones ([Figure S2](#mmc1){ref-type="supplementary-material"}C) showed that the antibody reacts with H4 and that the signal is strongly reduced upon phosphatase treatment ([Figure S2](#mmc1){ref-type="supplementary-material"}D), indicating that it recognizes phosphorylated H4. To determine whether it specifically reacts with H4T80ph, we isolated histones from H4T80A mutant cells. In contrast to wild-type histone H4, the antibody does not detect mutant histone H4T80A ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Together, these results therefore confirm that the antibody specifically recognizes H4T80ph in yeast.

Because the H4T80A mutant is sensitive to DNA-damaging agents, we asked whether H4T80ph levels might be regulated in response to DNA damage. Importantly, immunoblot studies confirmed that H4T80ph levels increase upon CPT treatment ([Figure 1](#fig1){ref-type="fig"}D). To investigate whether H4T80ph occurs at sites of DNA damage, we used a well-established experimental system in which addition of galactose induces a single, persistent DNA double-strand break (DSB) ([Figure S2](#mmc1){ref-type="supplementary-material"}F; [@bib35]). This system has been widely used before to monitor the recruitment of DNA repair factors and chromatin regulators to a DSB by chromatin immunoprecipitation (ChIP) ([@bib6], [@bib10], [@bib11], [@bib36], [@bib61], [@bib69]). Upon galactose induction, H4T80ph levels increase at the DSB site ([Figure 1](#fig1){ref-type="fig"}E), but not in an unrelated region, suggesting that H4T80ph is particularly accumulated at sites of DNA damage. Collectively, the above findings support that H4T80 phosphorylation promotes cell survival in response to DNA damage.

PAK Family Kinase Cla4 Phosphorylates Histone H4T80 {#sec2.2}
---------------------------------------------------

We next sought to identify the kinase(s) responsible for H4T80ph. Although yeast basophilic kinases commonly show a strong selectivity for arginine residues three amino acid residues upstream of the phosphorylation site (P-3), only four of them (Ipl1, Cla4, Ste20, and Skm1) are selective for arginine at the P-2 position ([@bib46]). As the role of Ipl1 in the regulation of chromosome condensation via phosphorylation of H3, but not H4, has been extensively characterized ([@bib27]), we focused on the other three kinases, which are members of the p21-activated kinase (PAK) family ([@bib72]). Cla4 is involved in septin ring assembly, actin polymerization, and cytokinesis ([@bib14], [@bib68]). Ste20 was first identified as an essential protein in the mating pathway ([@bib34]), although it also plays some overlapping functions with Cla4 ([@bib14]). Finally, less is known about the functions of Skm1, which is a paralog of Cla4 ([@bib44]). Notably, none of these three yeast kinases have been specifically linked to the DDR.

Deletion of *CLA4*, but not *SKM1* or *STE20*, results in DNA damage hypersensitivity ([Figure 2](#fig2){ref-type="fig"}A), suggesting that Cla4 is involved in the DDR. Moreover, immunoblot analysis showed that *cla4Δ* mutant cells exhibit a strong reduction in H4T80ph levels compared to wild-type cells ([Figure 2](#fig2){ref-type="fig"}B), indicating that Cla4 is required for H4T80 phosphorylation *in vivo*. To address whether Cla4 can directly phosphorylate H4 *in vitro*, we produced recombinant wild-type Cla4 (rCla4) and a kinase dead version (rCla4K594A; [Figure 2](#fig2){ref-type="fig"}C; [@bib68]). Importantly, wild-type Cla4, but not the kinase dead version, phosphorylates H4 in a mixture of free histones *in vitro* ([Figure 2](#fig2){ref-type="fig"}D). To determine whether Cla4 phosphorylates H4T80, we used a histone H4 peptide encompassing the region (residues 70--90). Notably, rCla4 phosphorylates histone H4T80 peptide, but not a version of this peptide in which T80 is replaced by alanine ([Figure 2](#fig2){ref-type="fig"}E). Taken together, these results indicate that Cla4 is responsible for H4T80 phosphorylation.Figure 2PAK Family Kinase Cla4 Phosphorylates Histone H4T80(A) Spot test for DNA damage sensitivity of different kinase deletion mutants as indicated. 10-fold serial dilutions were used.(B) Immunoblot analysis of purified yeast histones. Both wild-type and *cla4Δ* mutant cells were grown to exponential phase. Purified yeast histones were separated by SDS-PAGE in 17% acrylamide gels. Blots were probed with anti-H4T80ph antibody and then re-probed with an anti-H4 antibody as indicated. $\leftarrow$ corresponds to histone H4.(C) Coomassie-blue-stained gel showing purified wild-type glutathione S-transferase (GST)-Cla4 (rCla4) and the corresponding catalytically inactive mutant (rCla4K594A). $\leftarrow$ corresponds to GST-Cla4.(D) *In vitro* kinase assay using γ^32^P- ATP. Both recombinant wild-type Cla4 (rCla4) and a kinase inactive version (rCla4K594A) were incubated with either purified core histones or purified histone H4. Reactions were separated by SDS-PAGE in 17% acrylamide gels. Right panel shows Coomassie blue stained gel, and left panel shows the corresponding autoradiogram.(E) *In vitro* kinase assay using γ^32^P- ATP. rCla4 was incubated with a peptide encompassing Thr-80 (H4) or a version of it in which this residue was replaced by alanine (H4T80A). Reactions were separated in 17% acrylamide tricine gels. Right panel shows Coomassie blue stained gel, and left panel shows the corresponding autoradiogram.

Our *in vitro* assays revealed some Cla4 activity, although to a much lesser extent, toward other histones. In line with this, it has been reported that H3 is phosphorylated at an equivalent position (H3T80) in mammalian cells ([@bib23]). H3T80 is also preceded by a basic residue, although at the P-1 position, raising the possibility that Cla4 could be responsible for H3T80ph. However, in contrast to H4T80A, the H3T80A mutant does not display hypersensitivity to DNA damaging agents ([Figure S3](#mmc1){ref-type="supplementary-material"}C), further supporting the notion that Cla4 specifically phosphorylates H4T80 to promote cell survival in response to DNA damage.

To explore whether Cla4 phosphorylates H4T80 at sites of DNA damage, we first analyzed the DSB recruitment of Cla4 kinase by ChIP. Upon galactose induction, Cla4 is recruited to the DSB site ([Figure 3](#fig3){ref-type="fig"}A), suggesting that it plays a direct role in the DDR. Moreover, ChIP analysis revealed that H4T80ph accumulation at the DSB site is dependent on Cla4 ([Figure 3](#fig3){ref-type="fig"}B). Importantly, defective accumulation of H4T80ph in *cla4Δ* mutant cells is not due to impaired DSB induction ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Together, these results indicate that Cla4 is responsible for H4T80 phosphorylation at sites of DNA damage.Figure 3Cla4 Phosphorylates H4T80 at Sites of DNA Damage(A) ChIP-qPCR experiments showing Cla4-hemagglutinin (HA) recruitment to the DSB site before and after 2 hr of galactose induction. *PRP8* locus was used as a negative control. Graphs show mean + SEM of two biological replicates (^∗^p \< 0.05; t test).(B) ChIP-qPCR experiments showing H4T80ph enrichment at the DSB site after 2 hr of galactose induction in the indicated strains. Enrichment at the target loci were normalized to the *PRP8* reference locus. Data are represented as mean + SEM of three biological replicates (^∗^p \< 0.05; t test).

H4T80ph Regulates the DNA Damage Checkpoint {#sec2.3}
-------------------------------------------

To examine functions of H4T80ph, we next investigated the origin of the DNA damage hypersensitivity of the H4T80A mutant strain. We initially excluded the possibility that this phenotype was due to impaired expression of DDR genes by analyzing changes in gene expression profiles between wild-type and H4T80A mutant cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Importantly, genes exhibiting significant differential expression show no enrichment for DNA-damage-related Gene Ontology (GO) terms ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Moreover, analysis of 206 genes involved with cellular response to DNA damage stimulus (GO: 0006974) show almost no change in expression between H4T80A mutant and wild-type cells, particularly when contrasted with a randomly selected subset of 206 genes ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

We next explored whether H4T80ph was involved in DNA repair. In *Saccharomyces cerevisiae*, the major pathway for DSB repair is homologous recombination (HR), which is completely dependent on Rad52 ([@bib62]). Repair of CPT- or MMS-induced DNA damage requires Rad52-dependent HR, and therefore, *rad52Δ* cells are extremely sensitive to these drugs ([Figure S5](#mmc1){ref-type="supplementary-material"}A; note that *rad52Δ* cells are sensitive even to very low concentrations of CPT and MMS, at which H4R78A and H4T80A are not). If the DNA damage hypersensitivity of the H4T80A mutant was due to HR-mediated DNA repair defects, then mutation of H4T80A should not enhance *rad52Δ* phenotype. However, mutation of either H4R78A or H4T80A exacerbates the DNA damage hypersensitivity of *rad52Δ* cells ([Figure 4](#fig4){ref-type="fig"}A). Consistent with this, global genetic interaction studies have shown that deletion of *CLA4* exacerbates the DNA damage hypersensitivity of most mutants in the HR pathway, including *rad52Δ* ([@bib3], [@bib60]). It is therefore unlikely that the DNA damage hypersensitivity caused by the lack of H4T80ph is due to HR-mediated DNA repair defects per se.Figure 4H4T80ph Regulates the DNA Damage Checkpoint(A) Spot test for DNA damage sensitivity of different yeast mutants as indicated. 10-fold serial dilutions were used.(B) Immunoblot analysis of Rad53 and histone H2A phosphorylation levels. Wild-type or H4T80A mutant cells were arrested in G1 using α factor and then released in the presence of 20 μM CPT for 120 min. Samples were taken every 15 min. α factor was added again after 45 min to arrest cells in G1. Rad53 phosphorylation was evaluated by mobility shift in SDS-PAGE gels.(C) Flow cytometry analysis of the same samples taken in (B).(D and E) Spot test for DNA damage sensitivity of different yeast mutants as indicated. 10-fold serial dilutions were used.(F) Immunoblot analysis of Rad9-HA phosphorylation levels evaluated by mobility shift in NuPAGE Tris-acetate 3%--8% gel. The same experimental conditions as in (B) were used.

Accordingly, we assessed whether H4T80ph was involved in activation of the DDC, a signaling cascade initiated by the recognition of ssDNA by the apical Mec1 kinase and culminating in Mec1-dependent activation of the downstream kinase Rad53 ([@bib9]). To do so, we analyzed Rad53 phosphorylation levels upon CPT treatment. Both wild-type and H4T80A cells were synchronized in G1 using α factor and then released into S phase in the presence of CPT. H4T80A mutant cells exhibit stronger and prolonged activation of Rad53 compared to wild-type cells ([Figure 4](#fig4){ref-type="fig"}B), which is associated with a prolonged G2/M cell cycle arrest ([Figure 4](#fig4){ref-type="fig"}C; note that, unlike wild-type cells, H4T80A cells did not progress to G1 during the course of this analysis). Importantly, none of these phenotypes are detectable in the absence of genotoxic stress ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). Notably, phosphorylation of histone H2A serine 129 (γH2A), which is also substrate of Mec1 ([@bib16]), is not increased but actually decreased in H4T80A mutant cells ([Figure 4](#fig4){ref-type="fig"}B), suggesting that Rad53 hyperactivation observed in the H4T80A mutant is not caused by increased DNA-damage-induced Mec1 signaling. Mutation of H2AS129A abolishes γH2A and results in DNA damage hypersensitivity ([@bib16]). Therefore, we asked whether defective γH2A might be the origin of the DNA damage hypersensitivity of H4T80A cells. However, mutation of H4T80A exacerbates the DNA damage hypersensitivity of H2AS129A mutant cells ([Figure 4](#fig4){ref-type="fig"}D), supporting the notion that H4T80A mutant phenotype is not merely caused by defects in H2A phosphorylation.

We next explored whether improper regulation of Rad53 activation could be responsible for H4T80A mutant phenotype. To do so, we used a hypomorphic allele of *RAD53* (*rad53-R605A*) that has been previously shown to lower Rad53 activation levels ([@bib28], [@bib51]). This allele harbors a point mutation in the FHA2 domain, which binds phosphorylated Rad9 to mediate Rad53 activation. Strikingly, the DNA damage hypersensitivity of the H4T80A mutant can be rescued by the hypomorphic allele of *RAD53* (*rad53-R605A*; [Figure 4](#fig4){ref-type="fig"}E), confirming that H4T80A mutant phenotype is due to improper regulation of Rad53 signaling. To determine whether Rad9 is involved in Rad53 hyperactivation observed in H4T80A mutant cells, we analyzed Rad9 phosphorylation levels upon CPT treatment. Interestingly, H4T80A mutant cells show increased levels of Rad9 phosphorylation that persist for longer periods of time compared to wild-type cells ([Figure 4](#fig4){ref-type="fig"}F). Collectively, these results indicate that H4T80ph plays an important role in regulating Rad9-dependent activation of Rad53 and that its absence leads to a persistent cell cycle arrest that compromises cell viability.

H4T80ph Controls Rtt107 Recruitment to Sites of DNA Damage {#sec2.4}
----------------------------------------------------------

Histone post-translational modifications play major roles in recruiting Rad9 to sites of DNA damage, where it specifically binds histone H3 methylated at lysine 79 (H3K79me) via its Tudor domain and γH2A via its BRCA1 C-terminal (BRCT) domains ([@bib19], [@bib22]). Interestingly, H3K79 and H4T80 are located next to each other in the nucleosome structure ([Figure 5](#fig5){ref-type="fig"}A), suggesting that H4T80 phosphorylation and/or the recruitment of a specific histone modification reader might regulate Rad9 chromatin binding. In line with this idea, it was recently shown that Rtt107 binds γH2A via its BRCT5/6 domains to outcompete Rad9 and downregulate Rad53 activation ([@bib51]). However, the mechanism driving the transition from checkpoint activation (Rad9-γH2A complex) to inactivation (Rtt107-γH2A complex) remained elusive. We therefore explored whether H4T80ph could trigger this switch by regulating timely recruitment of Rtt107. To do so, we analyzed the DSB recruitment of Rtt107 in wild-type and H4T80A mutant cells by ChIP. Consistent with a role of H4T80ph in Rtt107 recruitment, mutation of H4T80A significantly reduces Rtt107 enrichment at the DSB site ([Figure 5](#fig5){ref-type="fig"}B). Importantly, defective recruitment of Rtt107 in H4T80A mutant cells is not due to impaired DSB induction ([Figure S6](#mmc1){ref-type="supplementary-material"}). Together, these results indicate that H4T80ph promotes Rtt107 recruitment to sites of DNA damage.Figure 5H4T80ph Controls Rtt107 Recruitment to Sites of DNA Damage(A) Ribbon structure of H3 L1 loop and H4 L2 loop showing that the side chains of H4T80 and H3K79 are in close proximity.(B) ChIP-qPCR experiments showing Rtt107-HA recruitment to regions near the DSB after 2 hr of galactose induction. Enrichment at the target loci were normalized to the *PRP8* reference locus. Data are represented as mean + SEM of three biological replicates (^∗^p \< 0.05; t test).(C) Immunoblot analysis of Rtt107-HA and Rad53 phosphorylation levels evaluated by mobility shift in SDS-PAGE gels. Wild-type or H4T80A mutant cells were arrested in G1 using α factor and then released in the presence of 20 μM CPT for 60 min. Samples were taken every 15 min.(D) RT-qPCR experiments showing *RTT107* and *RNR3* mRNA levels before and after CPT treatment. Data were normalized to *ACT1* and represent mean + SEM of three biological replicates.(E) A schematic of the Rtt107 protein is shown (upper panel). Point mutations disrupting BRCT3/4 and BRCT5/6 pairs, respectively, are shown. The lower panel shows an immunoblot analysis of Rtt107-FLAG *in vitro* peptide binding assays. Wild-type and Rtt107 mutant cells were grown to exponential phase. Whole-cell extracts were then prepared and incubated with immobilized peptides as indicated.

Recruitment of Rtt107 to sites of DNA damage correlates with its Mec1-dependent phosphorylation ([@bib2]). In agreement with the hypothesis that H4T80ph is important for Rtt107 recruitment and subsequent Rad53 inactivation, mutation of histone H4T80A impairs DNA-damage-induced Rtt107 phosphorylation and results in Rad53 hyperphosphorylation ([Figure 5](#fig5){ref-type="fig"}C). We noticed that Rtt107 protein abundance is significantly increased upon CPT treatment and that this increase is milder in H4T80A mutant cells compared to wild-type cells ([Figure 5](#fig5){ref-type="fig"}C). Interestingly, *RTT107* mRNA levels do not significantly change upon CPT treatment and/or H4T80A mutation ([Figure 5](#fig5){ref-type="fig"}D), indicating that differences in Rtt107 protein abundance are not due to transcriptional changes. In contrast, *RNR3* mRNA levels, which are known to be regulated by the DDC, are markedly increased upon CPT treatment, especially in the H4T80A mutant ([Figure 5](#fig5){ref-type="fig"}D). Collectively, these results suggest that Rtt107 protein may be stabilized when recruited to sites of DNA damage.

To investigate whether Rtt107 directly binds H4T80ph, we performed *in vitro* peptide pull-down experiments using yeast whole-cell extracts. Rtt107 binds to a peptide spanning histone H4T80 but only when T80 is phosphorylated ([Figure 5](#fig5){ref-type="fig"}E), further supporting the notion that H4T80ph promotes Rtt107 chromatin recruitment. Because Rtt107 contains multiple BRCT domain pairs, which commonly function as phosphoprotein-binding modules ([@bib38]), we then questioned which one was responsible for Rtt107-H4T80ph interaction. It was recently shown by mutational analysis that Rtt107 recruitment to sites of DNA damage is mediated not only by BRCT5/6, which bind γH2A, but also by BRCT3/4, whose binding site remains unknown ([@bib39]). Using Rtt107 point mutants that disrupt either BRCT3/4 or BRCT5/6 (K426M and K887M, respectively; [@bib39]), we observed that Rtt107 BRCT3/4 pair, but not BRCT5/6, is absolutely required to bind H4T80ph *in vitro* ([Figure 5](#fig5){ref-type="fig"}E). Taken together, these results support a model in which histone H4T80ph promotes Rtt107 chromatin recruitment via its interaction with BRCT3/4.

H4T80ph Triggers DNA Damage Checkpoint Recovery {#sec2.5}
-----------------------------------------------

Our results support that, after DNA damage, Cla4 phosphorylates H4T80 to promote Rtt107 recruitment and consequent Rad53 inactivation. In this model, the absence of H4T80ph would allow prolonged Rad9 persistence on chromatin driving excessive Rad53 activation, which results in DNA damage hypersensitivity. Because H3K79 lies in close proximity to H4T80 ([Figure 5](#fig5){ref-type="fig"}A), we hypothesized that H4T80ph-bound Rtt107 could directly counteract Rad9 binding to H3K79me. In line with this hypothesis, deletion of *DOT1*, the only H3K79 methyltransferase, suppresses the DNA damage hypersensitivity of H4T80A and *cla4Δ* mutant cells ([Figures 6](#fig6){ref-type="fig"}A and 6B). Moreover, similar results were obtained by mutating H3K79A ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B), highlighting the specific crosstalk between H3K79me and H4T80ph. Together, these results further support the notion that H4T80ph plays an important role in regulating Rad9-dependent activation of Rad53.Figure 6H4T80ph Triggers DNA Damage Checkpoint Recovery(A and B) Spot test for DNA damage sensitivity of different yeast mutants as indicated. 10-fold serial dilutions were used.(C) ChIP-qPCR experiments showing Rtt107-HA recruitment to regions near the DSB after 2 hr of galactose induction in the indicated strains. Enrichment at the target loci were normalized to the *PRP8* reference locus. Data are represented as mean + SEM of three biological replicates (^∗^p \< 0.05; t test).(D) Immunoblot analysis of Rtt107-HA and Rad53 phosphorylation levels evaluated by mobility shift in SDS-PAGE gels. Indicated strains were arrested in G1 using α factor and then released in the presence of 20 μM CPT for 120 min. Samples were taken every 15 min.

Because depletion of H3K79me suppresses the DNA damage hypersensitivity of H4T80A mutant cells, we asked whether it might also restore the DSB recruitment of Rtt107. However, H3K79A H4T80A double-mutant cells show a similar defect in Rtt107 recruitment compared to H4T80A mutant cells ([Figure 6](#fig6){ref-type="fig"}C), indicating that, even in the absence of H3K79me, H4T80ph is still necessary to properly recruit Rtt107 to sites of DNA damage. Therefore, we next investigated whether depletion of H3K79me suppressed Rad53 hyperactivation observed in H4T80A mutant cells. Upon CPT treatment, H4T80A mutant cells exhibit defective Rtt107 phosphorylation, along with stronger and prolonged phosphorylation of Rad53, compared to wild-type cells ([Figure 6](#fig6){ref-type="fig"}D). Surprisingly, *DOT1* deletion partially rescues defective Rtt107 phosphorylation in H4T80A mutant cells ([Figure 6](#fig6){ref-type="fig"}D), suggesting that reduced Rad9 binding may favor increased Rtt107 recruitment. However, we did not observe a similar behavior by ChIP, indicating that Rtt107 cannot be stably recruited in the absence of H4T80ph. Most importantly, we found that deletion of *DOT1* suppresses Rad53 hyperphosphorylation in H4T80A cells ([Figure 6](#fig6){ref-type="fig"}D), further suggesting that this phenotype is due to Rad9 persistence on chromatin. Collectively, these results support the notion that, in response to DNA damage, Rtt107 and Rad9 bind to the same nucleosome core region in order to regulate Rad53 activation. It is important to note that Rtt107 protein upregulation upon CPT treatment is transient ([Figure 6](#fig6){ref-type="fig"}D), suggesting that there is a relatively narrow window of opportunity for it to be recruited to sites of DNA damage. Notably, we observed that H4T80A mutant cells downregulate Rtt107 protein levels despite the fact that Rad53 has not been inactivated yet ([Figure 6](#fig6){ref-type="fig"}D), critically missing this time window. Therefore, we conclude that H4T80ph is crucial for timely Rtt107-dependent downregulation of Rad53 activity.

Discussion {#sec3}
==========

Reversal of the DDC not only requires efficient repair of DNA lesions but also termination of the checkpoint signaling to allow resumption of the cell cycle. Whereas the molecular mechanisms regulating DDC activation are well characterized, our understanding of how DDC recovery is initiated and controlled is still limited. Chromatin structure regulates all DNA-based processes, including the DNA damage response, and it is well established that histone post-translational modifications, such as H3K79me and γH2A, play major roles in DDC activation ([@bib19], [@bib22]). Given the toxicity of persistent DDC activation, it seems therefore surprising that no DDC recovery-dedicated histone post-translational modification had been discovered so far. Our work identifies H4T80ph, a DNA-damage-induced histone modification, as an important regulator of recovery from DNA damage.

H4T80ph is important for cell survival to DNA damage. Its absence causes prolonged Rad9-dependent activation of Rad53 and persistent cell cycle arrest. In particular, we show that H4T80ph is required for Rtt107-dependent inactivation of Rad53. It was proposed that Rtt107 prevents excessive Rad9-dependent Rad53 activation by binding to γH2A ([@bib51]). However, in this scenario, both proteins would compete for the same binding site, and therefore, the mechanism triggering the switch between checkpoint activation and recovery would not be apparent. Moreover, it was not clear how H3K79me-bound Rad9 would be outcompeted. Our findings support a model in which DNA-damage-dependent phosphorylation of H4T80 determines timely recruitment of Rtt107, the consequent displacement of Rad9, and the interruption of the checkpoint-signaling cascade, leading to resumption of normal cell growth ([Figure 7](#fig7){ref-type="fig"}).Figure 7Model of DNA Damage Checkpoint Recovery InitiationSchematic model depicting the role of H4T80ph in the transition from checkpoint activation to checkpoint recovery. In response to genotoxic stress, Rad9 recruitment to sites of DNA damage, via interaction with H3K79me and γH2A, drives DDC activation. Cla4-dependent H4T80 phosphorylation triggers DDC recovery by recruiting Rtt107, which displaces Rad9 from H3K79me and γH2A, thereby interrupting the signaling cascade.

Cla4, the kinase responsible for this histone modification, plays key roles in promoting assembly of the septin ring at the bud neck to regulate polarized growth and cytokinesis ([@bib14], [@bib68]). Our results demonstrate that it additionally has an important role in regulating the DDC. Interestingly, DDC proteins are known to regulate morphogenetic events during replication stress ([@bib18]). Our findings therefore highlight a regulatory network where Cla4, which itself seems to be a checkpoint target ([@bib73]), plays a pivotal role by coordinating cell morphogenesis and reversal of the DDC.

Because reversal of the DDC is crucial for cell survival following DNA damage, similar mechanisms are expected to operate in higher eukaryotes as well. In this regard, different large-scale mass spectrometry studies identified H4T80ph in mammalian cells ([@bib7], [@bib26], [@bib43], [@bib45], [@bib52], [@bib53], [@bib64]). Unfortunately, the specificity of the H4T80ph antibody toward yeast histone H4 sequence did not allow us to extend our studies to human cells ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Nevertheless, there are six PAK family members in humans (PAK1--6; [@bib72]), where PAK1 seems to be the closest homolog of Cla4, because it is known to be involved in cell morphogenesis and cytokinesis and has already been linked to the DDR ([@bib40], [@bib65], [@bib70]). Interestingly, increased PAK1 expression and activity have been well documented in several human cancers ([@bib58]). It is well known that the DDC acts as a barrier during early tumorigenesis, and that its inactivation fosters tumor progression ([@bib5], [@bib21]). In line with this, PAK1 was shown to promote melanoma chemoresistance by suppressing DNA-damage-sensing pathways ([@bib25]). Further studies will be therefore necessary to determine whether H4T80ph-dependent downregulation of the DDC plays a role in human cancer biology.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-H4T80phOrygenThis study; RRID: [AB_2313773](nif-antibody:AB_2313773){#interref0085}Anti-H4AbcamRRID:[AB_296888](nif-antibody:AB_296888){#intref0010}Anti-Rad53AbcamRRID:[AB_2687603](nif-antibody:AB_2687603){#intref0015}Anti-γH2AAbcamRRID:[AB_301630](nif-antibody:AB_301630){#intref0020}Anti-HAAbcamRRID:[AB_307019](nif-antibody:AB_307019){#intref0025}Anti-FLAGSigmaRRID:[AB_262044](nif-antibody:AB_262044){#intref0030}**Bacterial and Virus Strains**BL21 (DE3)New England BiolabsCat. No. C2527I**Chemicals, Peptides, and Recombinant Proteins**H4T80 peptideGeneCustThis studyH4T80ph peptideGeneCustThis studyH4T30ph peptideGeneCustThis studyH4T96ph peptideGeneCustThis studyBiotinylated H4T80 peptideGeneCustThis studyBiotinylated H4T80ph peptideGeneCustThis studyHuman H4T80 peptideGeneCustThis studyHuman H4T80ph peptideGeneCustThis studySulfolink Coupling ResinThermoFisherCat.No. 20402Protease inhibitorsRocheCat.No. 11697498001Phosphatase inhibitorsRocheCat.No. 04906845001CamptothecinSigmaCat.No.C9911Methyl methanesulfonateSigmaCat.No.129925α-factorGenScriptCat.No.RP01002Sytox GreenInvitrogenCat.No.S7020Dynabeads MyOne Streptavidin C1ThermoFisherCat.No. 65001Calf histonesRocheCat.No. 10223565001DNase IZymo ResearchCat.No E1009-ANEXTflex Poly(A) beadsBioo ScientificNOVA-512981**Critical Commercial Assays**Fast SYBR Green Master MixThermoFisherCat.No.4385612NEXTflex RNA-seq kitBioo ScientificNOVA-512913**Deposited Data**RNA-seq dataThis study<https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7090/>Unprocessed imaging dataThis study<https://doi.org/10.17632/yjwrsb92fg.1>**Experimental Models: Organisms/Strains***S. cerevisiae* wild type and mutant strains background: W303This study[Table S1](#mmc1){ref-type="supplementary-material"}**Oligonucleotides**qPCR 0.2 kb from HOThis studyN/Aup: CCCATCGTCTTGCTCTTGTTlow: ATCCGTCCCGTATAGCCAATqPCR 1 kb from HO up: CAAGGATGCCCTTGTTTTGT low: TTTTGACGGCCAATCTTTTCThis studyN/AqPCR 5 kb from HOThis studyN/Aup: CCAAGGAACTAATGATCTAAGCACAlow: CATGTTGGTACTCTAAATCACCTCCqPCR *PRP8*This studyN/Aup: GAGTGTGGCTAAATTTCTTAAGAGGlow: TCGAATACTCTCAGGCATCATTTCTqPCR *RTT107*This studyN/Aup: CTTGCTACTTTGTGTGAGCTTGATlow: TTTGTTTGGATGAAGAGTAAGCTGqPCR *RNR3*This studyN/Aup: AGGTCGTGGTAAAACAATTAAAGClow: TGTTGGTTTGTCTTCCTGTTACATqPCR *ACT1*This studyN/Aup: GAAATGCAAACCGCTGCTCAlow: TACCGGCAGATTCCAAACCC**Recombinant DNA**pMR206 (*TRP1-HHT2-HHF2)*([@bib63])N/ApMBV80 (GST-*CLA4)*([@bib68])N/ApMBV81 (GST-*CLA4K594A)*([@bib68])N/ApMBS362 (*RAD53-R605A::kanMX6)*([@bib51])N/A**Software and Algorithms**fastQC([@bib1])N/Atrim-galore([@bib31])N/ASTAR universal RNA seq aligner([@bib15])N/AGenomicAlignments package([@bib32])N/ADESeq2 package([@bib41])N/AclusterProfiler package([@bib71])N/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Prof. Tony Kouzarides (<t.kouzarides@gurdon.cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

All *Saccharmoyces cerevisae* strains used in this study are derivatives of W303 background. Integrations and deletions were performed using one-step PCR-based methods ([@bib29]). Histone point mutants were shuffled by counter-selection on 5-FOA. Genotypes are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. All strains were routinely grown in YPAD at 30°C.

Method Details {#sec4.4}
--------------

### DNA damage sensitivity assay {#sec4.4.1}

Yeast strains were cultured overnight to stationary phase. Cultures were then diluted to OD~600~ = 0.5 in sterile water. 10-fold serial dilutions were prepared and 5 μl volumes were spotted onto the corresponding plates. Images were taken 2-3 days later.

### H4T80ph antibody purification {#sec4.4.2}

The H4T80ph antibody was produced using a 90-day sheep immunization protocol (Orygen Antibodies Ltd, UK). Unmodified and modified peptides columns were prepared by coupling either H4T80 or H4T80ph peptides to a sulfolink resin. Sera were first incubated with H4T80 column for 1 hour on rotation at room temperature. Supernatant was recovered and incubated with H4T80ph column for 1 hour on rotation at room temperature. H4T80ph column was then washed 6 times with TBS, and antibodies were eluted in 100mM Glycine pH 2.5. Elution was quickly neutralized with ice-cold 1M TrisHCl ph 8.8 solution, and dialyzed overnight in TBS + 10% glycerol.

### Yeast histone purification {#sec4.4.3}

Yeast strains were cultured overnight to stationary phase. Next day, cells were grown in 1l of YPD for 3-4 generations to OD~600~ = 1. Cells were then collected, washed with water and frozen in liquid nitrogen. The cell pellet was resuspended in SP buffer (1M Sorbitol; 50mM potassium phosphate pH 6.8, 14mM β-mercaptoethanol) and spheroplasted by zymolyase digestion. Nuclei were then prepared by douncing in Lysis buffer (18% Ficoll-400 \[w/v\]; 20mM potassium phosphate pH 6.8; 1mM MgCl~2~; 0.5mM EDTA) supplemented with both protease and phosphatase inhibitors (Roche). After spinning down in a benchtop centrifuge, supernatant was recovered and nuclei were pelleted by spinning at 20,000 rpm for 30 minutes in a Beckman SW-41 Ti rotor. Nuclei were then resuspended in NP buffer (0.34M sucrose; 20mM Tris-HCl pH 7.4; 50mM KCl; 5mM MgCl~2~) supplemented with both protease and phosphatase inhibitors (Roche) and pelleted by spinning at 17,000 rpm for 30 minutes in a Beckman SW-41 Ti rotor. Nuclei were washed three times with Buffer A (10mM Tris-HCl pH 8.0; 0.5% NP-40 \[v/v\]; 75mM NaCl) supplemented with both protease and phosphatase inhibitors (Roche). Histones were then extracted in Buffer B (10mM Tris-HCl pH 8; 400mM NaCl; 0.2M H~2~SO~4~) for 1 hour on rotation at 4°C and TCA precipitated.

### Western blot {#sec4.4.4}

Total protein extracts were prepared as previously described ([@bib47]). Cells were washed twice with 1 mL of 20% \[w/v\] TCA and disrupted by vortexing for 4 minutes using acid-washed glass beads. Extracts were then neutralized by adding 1M Tris base and boiled in Laemmli buffer. For Rad53 and Rtt107 phosphorylation analysis, total protein extracts were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 7% acrylamide gels. Rad9 phosphorylation analysis was performed using NuPAGE Tris-acetate 3 to 8% gels and following the manufacturer's instructions (ThermoFisher). For H4T80 phosphorylation analysis, purified yeast histones were separated by SDS-PAGE in 17% acrylamide gels. Every experiment was repeated at least two (three in most cases) independent times. Representative blots are shown.

### Chromatin Immunoprecipitation (ChIP) {#sec4.4.5}

For the inducible DSB experiments, the corresponding yeast strains were grown in YP medium containing 2% raffinose until they reached OD~600~ = 0.5. Then, 2% galactose was added to induce expression of the HO endonuclease and 100 mL of yeast cultures per ChIP experiment were collected at the indicated times. Cells were cross-linked with 1% formaldehyde for 15 minutes at room temperature, and the reaction was quenched with 125mM glycine. Cells were resuspended in ChIP SDS buffer (1% SDS, 10 mM EDTA, 50 mM Tris HCl pH 8.0) supplemented with protease inhibitors (Roche) and disrupted with glass beads by using a FastPrep instrument (MP Biomedicals). Chromatin was sonicated (Bioruptor Pico, Diagenode; 10 cycles, 30 s on/off) to yield an average DNA fragment of 300-500 base pairs, and diluted 10 times in ChIP IP buffer (0.01% SDS, 1.1%Triton X-100, 167mM NaCl, 1.2mM EDTA, 16.7mM Tris HCl pH 8.0) supplemented with protease inhibitors (Roche) prior to overnight immunoprecipitation on rotation at 4°C. Next day, 50μl of protein G dynabeads were added, and samples were incubated again on rotation at 4°C for 2 hours. Then, dynabeads were washed twice with the following buffers: TSE 150 (1% Triton X-100, 0.1%SDS, 150 mM NaCl 2 mM EDTA, 20 mM Tris HCl pH 8.0), TSE 500 (1% Triton X-100, 0.1%SDS, 500 mM NaCl 2 mM EDTA, 20 mM Tris HCl pH 8.0) and LiCl buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris HCl pH 8.0). DNA was eluted at 65°C in elution buffer (100 mM NaHCO~3~, 1% SDS), and cross-linking was reverted by overnight incubation at 65°C. Samples were treated with 0.5 mg/ml of RNase A at 37°C for 2 h. DNA was purified using the ChIP DNA Clean & Concentrator kit (Zymo Research). Relative DNA amounts were determined by qPCR using Fast SYBR Green Master Mix (Applied Biosystems). Primer pairs used for amplification are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. For each strain and/or condition, three independent colonies were grown and processed. The mean values +SEM derived from three biological replicates were plotted using Prism (GraphPad Software, Inc.).

### Recombinant protein purification {#sec4.4.6}

Plasmids are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Expression of either GST-Cla4 or GST-Cla4K594A fusions in BL21 (DE3) cells was induced with 0.2mM IPTG for 4h at 20°C. Cells were then lysed by sonication in PBS + 0.1% \[v/v\] Tween-20 supplemented with protease inhibitors, and clarified lysate was incubated with glutathione-agarose beads for 1h at 4°C. Immobilized GST fusion proteins were washed extensively with PBS + 0.1% \[v/v\] Tween 20 and then with PBS. Immobilized GST-Cla4 and GST-Cla4K594A were then used for kinase reactions.

### *In vitro* phosphorylation assays {#sec4.4.7}

Kinase reactions were performed for 1h at 30°C in Kinase buffer (50mM Tris-HCl pH 7.5; 10mM MgCl~2~; 1mM DTT; 150mM NaCl; 50mM β-glycerolphosphate; 0.05% \[v/v\] NP-40; 50mM cold ATP and 0.37MBq (10μCi ϒ^32^P-ATP), using 35 ng of GST-Cla4 or GST-Cla4K594A enzyme and 1μg calf H4, 4μg calf histone mixture (H2A, H2B, H3, H4), 2μg H4 peptide (residues 70-90) or 3μg of H4T80A peptide (residues 70-90) as substrates. Reactions on histones were separated by SDS-PAGE in 17% acrylamide gels, whereas reactions on peptides were resolved in 17% acrylamide Tricine gels. Gels were stained with Coomassie brilliant blue to visualize proteins and peptides, dried and exposed to film. Bands were quantified using ImageJ software. The mean values +SEM derived from two independent experiments were plotted using Prism (GraphPad Software, Inc.).

### Flow cytometry analysis {#sec4.4.8}

Cell pellets were resuspended in ice-cold 70% \[v/v\] ethanol and incubated at 4°C overnight. Cells were then washed with 50mM Tris-HCl pH 8.0, and incubated with 0.4mg/ml RNase A at 37°C overnight. After treatment with pepsin for 30 min at 37°C, cells were resuspended in 1μM Sytox Green solution and analyzed using BD FACS Calibur flow cytometer.

### RNA library preparation {#sec4.4.9}

For each strain, three independent colonies were grown in YPD medium to OD~600~ = 0.6, and total RNA was prepared by hot-phenol extraction. RNA was subjected to DNase I treatment (catalog number E1009-A; Zymo Research) and poly-A mRNA was purified using poly-T oligo-attached magnetic beads (NEXTflex^®^ Poly(A) Beads, catalog number NOVA-512981) according to the manufacturer's instructions. RNA quantity and purity were assessed using an Agilent high-sensitivity RNA screen tape system (catalog number 5067-5579; Agilent Technologies) and Qubit (Molecular Probes, Invitrogen). 200 ng of polyA were used to prepare libraries with the NEXTflex RNA-seq kit (NOVA-512913, Illumina) according to the manufacturer's instructions. Samples were barcoded and combined at uniform molarity to create a single pool, which was sequenced in a single-end 75-bp run on an Illumina NextSeq machine.

### Global differential expression analysis {#sec4.4.10}

Quality control of raw fastq reads was conducted using fastQC ([@bib1]). Raw reads were trimmed to remove adaptor contamination and poor-quality bases using trim-galore ([@bib31]) with parameters "--illumina -q 20--stringency 5 -e 0.1--length 30--trim-n." Trimmed reads were mapped against the R64-1-1 *Saccharomyces cerevisiae* genome using the STAR universal RNA seq aligner ([@bib15]) with parameters "--outSAMmultNmax 300--outSAMstrandField intronMotif." All differential gene expression analyses were conducted in R. Gene counts were generated for all samples at the transcript level by using the summarizeOverlaps function in the GenomicAlignments package ([@bib32]) using mode "Union." Gene models for all transcripts were taken from the Ensembl v91 R64-1-1 *Saccharomyces cerevisiae* dataset. Differential gene expression analysis was conducted for H4T80A mutant samples versus wild-type samples using the DESeq2 package ([@bib41]). P values were adjusted using the Benjamini and Hochberg multiple testing correction. Significantly differentially expressed genes were identified based on a fold-change of 2-fold or greater (up- or downregulated) and an adjusted p value less than 0.05. Gene ontology analysis was conducted using the clusterProfiler package ([@bib71]).

### RT-qPCR {#sec4.4.11}

For each strain, three independent colonies were grown in YPD medium to OD~600~ = 0.4. Cells were arrested in G1 using α-factor, and then released in the presence of 20μM CPT for 45 min. Total RNA was prepared by hot-phenol extraction, and RNA quantity and purity were assessed using a NanoDrop 1000 instrument. 10 μg of total RNA were treated with TURBO DNase (Invitrogen; Catalog number AM2238). RNA was purified using RNA Clean & Concentrator Kit (Zymo; Catalog number R1016), and cDNA was prepared using Superscript III reverse transcriptase (Invitrogen; Catalog number 18080). Expression levels of individual transcripts were determined by qPCR using Fast SYBR Green Master Mix (Thermo; Catalog number 4385612) and oligonucleotides listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Relative levels were determined by normalization to the *ACT1* mRNA in each sample. The mean values +SEM derived from the three biological replicates were plotted using Prism (GraphPad Software, Inc.).

### *In vitro* peptide pull-downs {#sec4.4.12}

Yeast cells were grown to exponential phase and whole cell extracts were prepared using glass beads in binding buffer (20mM HEPES pH 7.9; 150mM NaCl; 1% \[v/v\] NP-40; 1mM DTT; 20% \[v/v\] glycerol) supplemented with both protease and phosphatase inhibitors. For peptide immunoprecipitation, 4μg of the corresponding peptide were diluted in 1ml of binding buffer and incubated with 75μl of Dynabeads MyOne Streptavidin C1 for 60 minutes at room temperature. Beads were washed twice with binding buffer. 0.5mg of whole cell extract was then incubated with beads for 3 hours at 4°C and washed 6 times with 300mM NaCl binding buffer. Immunoprecipitated proteins were then separated by SDS-PAGE in a 17% acrylamide gel.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

ImageJ was used for quantification of *in vitro* kinase assays. Microsoft excel software was used to perform all statistical analyses. Statistical differences were determined by two-tailed Student t test. Significance is denoted as ^∗^ for p \< 0.05.

Data and Software Availability {#sec4.6}
------------------------------

The accesion number for the RNA-seq data reported in this paper is \[ArrayExpress\]: \[E-MTAB-7090\].

Unprocessed imaging data are deposited on Mendeley Data:

<https://doi.org/10.17632/yjwrsb92fg.1>
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